Biotechnology
Pharmaceuticals
South Korea's biotech ambitions overshadowed by scandals
Clinical failures and fraud allegations overshadow industry touted as next frontier
Pharmaceuticals
Biogen and Japanese partner Eisai resurrect Alzheimer's drug
Shares of US company gain 27%, make up ground lost after trial's abandonment
Business deals
Singapore-based VC nears first close of $500m tech fund
Vickers Venture Partners plans to invest in biotechnology and artificial intelligence
Biotechnology
Fujifilm's Komori says health care can double to $10bn business
CEO sees M&A boosting scale while mainstay copier operations slow down
Business trends
3D bioprinters turn out liverlike tissues and 'biochips' in Japan
US, EU and Chinese startups also in race to revolutionize medicine
Markets
Henlius Biotech expects to raise up to $477m from Hong Kong IPO
Cornerstone investors have agreed to invest about $140 million
Economy
Singapore may avoid recession after production beats forecasts
Electronics output stabilized in July after sharp drops in previous months
Pharmaceuticals
Dr. Reddy's quarterly profit beats estimates on gains from U.S. pact
Sale of three drug brands also helps Indian pharmaceutical firm
China tech
China tech stocks soar as Nasdaq-style board for startups opens
Around 25 companies debut on Star Market with some shares jumping over 100%
Interview
Japan chipmaker to drop Toshiba name, seeking new start with IPO
Weak demand, plant power outage and management crisis plague company
Biotechnology
Chinese 'baby editing' scientist retreats from flagship company
Co-founder of Direct Genomics replaces He Jiankui as chairman and buys out stake
Opinion
Samsung, the hedge fund and the law
Legal pressures on South Korea's biggest company could help bring corporate reform
Companies
Samsung offices raided in BioLogics accounting probe
Prosecutors to weigh questioning senior executives at electronics maker
Companies
India's Lupin targets generic potential of biotech drugs
Expiring patents open window for launch in Japan and Europe by year end
Markets
Samsung Biologics under scrutiny again over 2016 IPO
Korea Exchange suspected of loosening regulations to help listing
Startups
Biotech startup turns palm waste into high-value chemicals
Japan's GEI sees a market in making plantations more profitable and sustainable
Companies
Court suspends disciplinary action against Samsung BioLogics
Regulator's order to dismiss CEO on hold until conclusion of main lawsuit
Companies
S Korean pharma laid low by global retreat and Samsung scandal
Scandal compounds grim mood as international partnerships flop
Startups
Japanese spider-thread startup nets $44m for new Thai plant
Spiber hopes eco-friendly synthetic will satisfy '15% to 20%' of overall fiber demand